Trials / Completed
CompletedNCT00400335
Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
An Open Label Study to Evaluate the Impact of Novel Fixed-dose Testosterone/Dutasteride Combinations on the Relative Bioavailability of the Individual Dutasteride and Testosterone Components
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nanomilled testosterone | |
| DRUG | commercially available dutasteride | |
| DRUG | Nanomilled dutasteride |
Timeline
- Start date
- 2006-10-01
- First posted
- 2006-11-16
- Last updated
- 2012-06-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00400335. Inclusion in this directory is not an endorsement.